Health Condition 1: null- A benign gynaecological pathology for which the patient would be undergoing a surgical procedure Health Condition 2: O- Medical and Surgical
Conditions
Interventions
Intervention1: Cefazolin: Cefazolin is the drug of choice for surgical prophylaxis.The recommended dose of Cefazolin is 2g and should be given by intravenous route 30-60 minutes prior to surgical inci
Sponsors
Post Graduate Institute of Medical Education and Research
Eligibility
Inclusion criteria
Inclusion criteria: Patients undergoing elective gynecological surgeries such as â?? 1 Abdominal/Laparoscopic/Vaginal Hysterectomy 2 Surgeries for pelvic organ prolapse/stress urinary incontinence 3 Exploratory Laparotomies
Exclusion criteria
Exclusion criteria: 1 Emergency Procedures 2 Associated co-morbidities like diabetes, anemia (Hb 3 Patients with immuno-compromised conditions like retrovirus positive, renal disease, on immuno suppressive therapy or chemotherapy 4 Patients with autoimmune disorders. 5 Patients with localized skin infection 6 With suspected or proven malignancies 7 Suspected infective procedure 8 Known allergy to Cefazolin / Tinidazole 9 Not willing to participate 10 History of any antibiotic within 7 days before surgery 11 History of fever within 7 days before surgery 12 Unexpected Intra-operative complications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the difference in rates of surgical site infection, febrile morbidity and urinary tract infections in the two groups of surgical prophylactic antibioticsTimepoint: For 1 month post surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference in duration of hospital stay post surgery between two groups Timepoint: For 1 month post surgery | — |
Countries
India
Contacts
Public ContactDr Shivani Garg
Post Graduate Institute of Medical Education and Research
Outcome results
None listed